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Purpose: To evaluate the effect of Isotretinoin on tear secretion among 
patients with Acne Vulgaris.
Patients and Methods: In this prospective study patients who were 
candidate for Isotretinoin (Accutane) therapy for two months under-
went complete eye examination. The best corrected visual acuity was 
measureed and slit lamp examination of anterior segment, evaluation 
of tear break-up-time and Schirmer’s test were performed. The post 
surgical examination carried out two months post therapy consisted of 
complete eye examination and evaluation of dry eye level.
Results : Thirty nine patients entered the study. There were 5 patients 
complaining of eye strain before treatment, which rose to 19 patients 
after Isotretinoin therapy (P < 0.001). The tear break up time was 13 ± 
1 seconds which decreased to 9 ± 1 seconds (P < 0.001) after therapy 
and the Schirmer’s test mean reading was 22 ± 2 mm, which was re-
duced to 18 ± 5 mm (P < 0.001) after treatment. There were 4 patients 
with blepharitis before the treatment which rose to 19 patients after the 
end of Isotretinoin treatment (P < 0.001).
Conclusion: Isotretinoin usage (0.5 - 1 mg/kg for two months) impairs 
the tear secretion and causes dry eye and blepharitis among patients. 
Considering the young age of patients using this drug, some of them 
candidates for keratorefractive surgery, a history of Isotretinoin usage 
should be considered before commencing the surgery. We recommend 
postponing the refractive surgery among these patients until the signs 
of dry eye are subsided. 
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Introduction
Isotretinoin is a synthetic derivative of vitamin 
A (B-cis- Retinoic Acid) which is mostly used 
to treat Acne Vulgaris in young patients (1). This 
drug causes a reduction in oil secretion by skin 
sebaceous glands therefore reducing the severity 
of Acne Vulgaris. Pilosebaceous glands are the 
main affected part of the skin in patients with 
Acne Vulgaris. The mechanism of Acne for-
mation is not well known but several theories 
have been suggested. One theory is the increase 
in oil secretion which is more than the capacity 
of exit ducts and causes the accumulation of oil 
in extracellular space around secretary cells (2).
Another theory points to skin bacterial flora 
as the cause of Acne Vulgaris. In this theory 
the lipase formation by propionibacterium 
causes the breakdown of the secreted oil by 
pilosebaceous glands, which causes the subsequent 
Acne formation (2). Another theory is the irregularity 
among squamous cells in the entrance of oil canals 
which causes the closure of canals (2). This causes the 
oil to become trapped inside the gland and form the 
Acne (2). Some reasurchers think the pathogeneses of 
Acne is multi factorial and it is caused by all causes 
discussed above (3).
Nowadays Isotretinoin is the forefront of drugs used 
to treat Acne Vulgaris (1-3). Isotretinoin can modify 
the Acne formation as a drug which changes the 
proliferation of squamous cells. This drug has 
antibacterial activity and increases the secretion 
of peroxides and inhibits the propionibacterium 
growth (3). It also modifies the oil secretion from 
pilosebaceous glands (1).  Isotretinoin has some 
side effects on liver (4), heart and blood vessels (4) 
and also causes dry skin. Eyes are one of the most 
common affected organs. It causes dry eye and 
blepharoconjunctivitis (1). Other eye problems 
caused by this drug are reduced vision, contact 
lens intolerance, unusual secretion of meibomian 
glands, corneal and lens opacity, choroidal 
neovascularization and pupil edema (2, 5-7). One 
rare side effect is the change of corneal curvature 
which is reversible after drug termination (3). The 
use of drug in children and pregnant women is 
prohibited. In this prospective study the effect 
of Isotretinoin on tear break up time as well as 
Schirmer’s test among patients who used the 
drug to treat Acne Vulgaris was studied.
Patients and Methods
This study was performed as a before-after cross 
sectional study on patients with Acne Vulgaris 
coming to Novin Didegan Eye Clinic from 2009 
to 2010, who were candidates for Isotretinoin 
treatment for at least a two months period. The 
study was approved by the Novin Didegan Eye 
Clinic ethics committee and all patients gave 
informed consent before entering the study.
All patients with a history of antihistamine, 
beta-blocker, systemic carbonic anhydrase and 
antihypertensive agents usage were excluded 
from the study. All patients underwent complete 
eye examination and history taking before the 
treatment started. The complete eye exam includ-
ed Uncorrected Visual Acuity (UCVA) and Best 
Corrected Visual Acuity (BCVA) measurements 
using Snelen chart (Auto chart projector Nidek 
CP 670), as well as complete slit lamp examination, 
applanation tonometry and fundus examination with 
dilated pupil. Any sign of blepharitis was categorized 
based on table 1. The tear secretion was tested using 
Schirmer’s 1 test which studies the liquid portion of 
tear.
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To perform the test, Whatman paper (Whatman 
W&K Ballston Filter Paper No. 42) was placed for 
5 minutes in the lateral inferior portion of both eyes 
while the patient was looking at a distant object and 
blinked normally. The reading was then performed 
and if less than 10 mm of the paper was wet it was 
determined as positive (sign of dry eye).
The Tear Break-Up Time (T) test was performed 
before Tetracaine eye drop. After soaking the 
eye with fluorescein the patient was asked to 
blink several times for fluorescein to spread and 
the corneal surface was illuminated with cobalt 
blue light and observed using a slit lamp. The 
time for the appearance of spots in green colored 
cornea was measured. The time between the last 
blink and the appearance of the black spots was 
recorded. If this time was less than 10 seconds 
the test was considered positive (dry eye). The 
intraocular pressure was then measured using 
indirect fundoscopy. Patients were then given 
0.5 -1 mg/kg Isotretinoin based on the severity 
of their Acne Vulgaris for a 2 months period and 
the same eye examinations were repeated at the 
end of two months. The data were analyzed using 
SPSS program version 17.0 (SPSS Co, Chicago, 
Illinois.). 
Results
This study was performed on 78 eyes form 39 
patients treated with Isotretinoin. The average 
age of participants was 24 ± 0.5 years with 97.3 % 
of patients being female and 2/7 % being male. The 
average tear break up time was 13 ± 1 seconds 
before treatment which was reduced to 9 ± 1 
seconds after the treatment.The difference was 
statistically significant (P < 0.001) based on 
Mann-Whitney Test (Table 2).
The average Schirmer’s test results was 22 ± 2 mm 
before and 18 ± 5 mm after the treatment with the 
difference being statistically significant (P < 0.001) 
(Table 2), (Figure1).
Thirty five patients did not have blepharitis signs 
before the start of the study and 4 patients had mild 
signs of blepharitis. After the treatment 20 patients 
did not have any sign of blepharitis, 14 patients 
had weak signs, 3 had moderate and 2 had severe 
blepharitis (Table 2), (Figure 2). The difference 
was statistically significant (P < 0.001) based 
on Mann-Whitney test.
Before the start of the study 13 % of patients had dry 
eye symptoms like foreign body sensation, burning 
eyes and other symptoms which increased to 49 % 
after treatment (P < 0.001) ( Figure 3). 
Table 1: The method for classification of blepharitis among patients.
Patients’ findings Score Classification
No sign Zero -
Inflammation + redness or telangiectasia 
of eye lid margin + 1 Mild
Above signs + secretion on the margin of 
eyelid + 2 Moderate
Above signs + follicular conjunctiva and 
cellular corneal margin + 3        Severe
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Figure 2: The treatment’s effect on blepharitis among 
patients.
 Figure 3: Dry eye before and after treatment. 
Table 2: Test results and eye complications among patients before and after treatment.
                
Variables Pre Post P
Mean TBUT ± SD, Sec 13 ± 1 9 ± 1  < 0.001*
Mean Schimer’s Test ± SD, mm 22 ± 2 18 ± 5  < 0.001*
Blepharitis, N (%)
                      0
                      1
                      2












Dryness, N (%) 5 (13) 19 (49) 0.001**
                * Based on Mann-Whitney test.
                                ** Based on Mac-Nemar test.
 
Figure 1: The treatment’s effect on Schirmer’s test. 
Discussion
One of the most common side effects of Isotretinoin 
treatment is dry eye. The patients suffer from 
the symptoms of dry eye including foreign body 
sensation, feeling heavy eyelids, burning, itching, 
watering, dryness and a constant need for scrubbing 
their eyes and signs like redness of the eyes and 
blinking (6). 
In our study the Schirmer’s test and tear break 
up time tests changed significantly after a two 
months treatment with Isotretinoin, which is in 
line with other studies (1, 2). The changes in tear 
break time test results may be due to changes in 
tear secretion by meibomian glands as reported 
by Kermer et al., including meibomian glands 
atrophy, reduced gland density and increased 
tear osmolarity (7). In another study by Queiroga et 
al., (8) structural changes in cytology of conjunctiva 
was observed in patients treated with Isotretinoin. 
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The structural changes included a reduction of 
goblet cells and also reduction of cell nucleus size 
compared to cytoplasm which shows dysplastic 
changes of conjunctival cells.
Considering the changes in the liquid portion of tear 
demonstrated by Schirmer’s test our findings were 
in contrast with other studies. Rismond et al. (9) have 
reported no change of lacrimal glands activity based 
on Schirmer’s test among patients and they even 
reported increased liquid portion of the tear in some 
of their patients. They concluded that a reduction in 
meibomian glands activity after using Isotretinoin 
might cause a reactive over-secretion by lacrimal 
glands.
In a study by Chua et al. (1) increased eye secretion 
has been reported in patients treated using 
Isotretinoin. The exact mechanism of drug 
affecting the tear secretion by porcine and 
endocrine glands should be studied more 
before a solid conclusion could be reached 
on the mechanism of tear secretion changes 
among these patients. One aspect which might 
compromise the test results in studies is the use of 
dry eye medications. 
One of Isotretinoin usage consequences is 
anterior or posterior blepharitis (3). In a case 
report by Hazen et al.(10) the patient developed 
Keratitis- Ichthyosis- Deafness (KID) syndrome 
and the signs of blepharitis and keratitis developed 
to the point of neovascularization of cornea. In 
another study by Ellies et al. (5) on patients using 
Isotretinoin some patients developed blepharoker-
atoconjunctivitis (BKC). In our study the eyelid’s 
inflammation was caused by treatment which is in 
line with Ellies et al., findings (5). 
Conclusion
Isotretinoin usage (0.5 - 1 mg /kg for two months) 
impairs the tear secretion and causes dry eye 
and blepharitis among patients. Considering the 
young age of patients using this drug, some of 
them candidates for keratorefractive surgery, a 
history of Isotretinoin usage should be considered 
before commencing the surgery. We recommend 
postponing the refractive surgery among these 
patients until the signs of dry eye are subsided.
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